Literature DB >> 18284189

New protein clustering of breast cancer tissue proteomics using actin content as a cellularity indicator.

Ida Pucci-Minafra1, Patrizia Cancemi, Nadia Ninfa Albanese, Gianluca Di Cara, Maria Rita Marabeti, Antonio Marrazzo, Salvatore Minafra.   

Abstract

In the present study, we report the comparative proteome profiles of proteins solubilized from 37 breast cancer surgical tissues, normalized for the actin content. Blood-derived proteins were excluded from the analysis. Among the tumor-derived protein spots, a large proportion (39%) was found present in all patients. These included several glycolytic enzymes, detox and heat shock proteins, members of annexin and S100 protein families, cathepsin D, and two "rare" proteins, DDAH2 involved in the angiogenesis control, and the oncogene PARK7. Other proteins, such as psoriasin, galectin1, cofilin, peroredoxins, SH3L1, and others, showed sporadic presence and high expression level, which suggests their possible role for patient stratification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284189     DOI: 10.1021/pr700748m

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  13 in total

1.  Large-scale proteomic identification of S100 proteins in breast cancer tissues.

Authors:  Patrizia Cancemi; Gianluca Di Cara; Nadia Ninfa Albanese; Francesca Costantini; Maria Rita Marabeti; Rosa Musso; Carmelo Lupo; Elena Roz; Ida Pucci-Minafra
Journal:  BMC Cancer       Date:  2010-09-03       Impact factor: 4.430

2.  Park7 expression influences myotube size and myosin expression in muscle.

Authors:  Hui Yu; Jolena N Waddell; Shihuan Kuang; Christopher A Bidwell
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

3.  Effect of ELF-EMF Exposure on Human Neuroblastoma Cell Line: a Proteomics Analysis.

Authors:  Hadi Hasanzadeh; Mostafa Rezaie-Tavirani; Samaneh Sadat Seyyedi; Hakimeh Zali; Saeid Heydari Keshel; Majid Jadidi; Ali Abedelahi
Journal:  Iran J Cancer Prev       Date:  2014

4.  Retrospective Proteomic Screening of 100 Breast Cancer Tissues.

Authors:  Ida Pucci-Minafra; Gianluca Di Cara; Rosa Musso; Patrizia Cancemi; Nadia Ninfa Albanese; Elena Roz; Salvatore Minafra
Journal:  Proteomes       Date:  2017-07-07

5.  Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation.

Authors:  Miriam Buttacavoli; Nadia Ninfa Albanese; Gianluca Di Cara; Rosa Alduina; Claudia Faleri; Michele Gallo; Giuseppe Pizzolanti; Giuseppe Gallo; Salvatore Feo; Franco Baldi; Patrizia Cancemi
Journal:  Oncotarget       Date:  2017-12-23

6.  Proteomic Profiling of Colon Cancer Tissues: Discovery of New Candidate Biomarkers.

Authors:  Miriam Buttacavoli; Nadia Ninfa Albanese; Elena Roz; Ida Pucci-Minafra; Salvatore Feo; Patrizia Cancemi
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

7.  Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.

Authors:  Michèl Schummer; Jason Thorpe; Maria D Giraldez; Maria Giraldez; Lindsay Bergan; Muneesh Tewari; Nicole Urban
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

8.  Proteomics analysis of MKN45 cell line before and after treatment with Lavender aqueous extract.

Authors:  Mona Zamanian-Azodi; Mostafa Rezaie-Tavirani; Saeid Heydari-Kashal; Shiva Kalantari; Sona Dailian; Hakimeh Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012

9.  Donor age and long-term culture do not negatively influence the stem potential of limbal fibroblast-like stem cells.

Authors:  Laura Tomasello; Rosa Musso; Giovanni Cillino; Maria Pitrone; Giuseppe Pizzolanti; Antonina Coppola; Walter Arancio; Gianluca Di Cara; Ida Pucci-Minafra; Salvatore Cillino; Carla Giordano
Journal:  Stem Cell Res Ther       Date:  2016-06-13       Impact factor: 6.832

10.  Changes in the in vitro activity of platinum drugs when administered in two aliquots.

Authors:  Zaynab Al-Eisawi; Philip Beale; Charles Chan; Jun Qing Yu; Nicholas Proschogo; Mark Molloy; Fazlul Huq
Journal:  BMC Cancer       Date:  2016-08-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.